A positive view on a negative trial with DOAC after TAVR
This video was recorded at the Congress of the American College of Cardiology (ACC) 2022.
Megan Coylewright is interventional cardiologist at the Erlanger Health System in Chattanooga, TN, VS.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.